Nilotinib HCl

CAS 923288-95-3

General Information

Nilotinib, the active ingredient of nilotinib , belongs to the class of molecules termed antineoplastic agents, which inhibit the maturation, growth or spread of tumor cells. It is used for the treatment of chronic myeloid leukemia (CML) in patients exhibiting an abnormal chromosome called the Philadelphia chromosome.

About the API

Systematic name 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide, monohydrochloride, monohydrate
Trade name(s) Tasigna
Technology Synthetic
Molecular Formula C28H22F3N7O•HCl•H2O
Molecular Weight 584 g/mol
Therapeutic category Oncology
Available formulations Oral Solid